Medicare Enrolled
Dr. Sandy McGaffigan, M.D.
Neurology · Austell, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. McGaffigan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McGaffigan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. McGaffigan
Dr. Sandy McGaffigan is a neurology specialist in Austell, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. McGaffigan performed 587 Medicare services across 464 unique beneficiaries.
Between the years covered by Open Payments, Dr. McGaffigan received a total of $12,034 from 70 pharmaceutical and/or device companies across 612 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. McGaffigan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 41% volume in GA
$12,034 industry payments
Medicare Practice Summary
Medicare Utilization ↗587
Medicare services
Top 41% in GA for neurology
464
Unique beneficiaries
$104
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~29 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
246 | $92 | $282 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
73 | $64 | $179 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
64 | $56 | $197 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
47 | $121 | $374 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 42 | $204 | $484 |
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
39 | $49 | $157 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
24 | $248 | $729 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
15 | $76 | $244 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
14 | $147 | $604 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
12 | $200 | $679 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
11 | $216 | $786 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$12,034
Total received (2018-2024)
Avg $1,719/year across 7 years
Top 23% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
70
Companies
612
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,892 (98.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$142 (1.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,862
2023
$2,194
2022
$1,898
2021
$1,617
2020
$679
2019
$1,438
2018
$1,347
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$382
MDD US Operations, LLC
$209
Lundbeck LLC
$175
Novartis Pharmaceuticals Corporation
$174
ABBVIE INC.
$172
Biogen, Inc.
$158
Eisai Inc.
$144
Alexion Pharmaceuticals, Inc.
$142
ACADIA Pharmaceuticals Inc
$141
Sumitomo Pharma America, Inc.
$129
ANI Pharmaceuticals, Inc.
$124
Neurelis, Inc.
$108
Grifols USA, LLC
$91
ARGENX US, INC.
$82
Mallinckrodt Hospital Products Inc.
$80
JAZZ PHARMACEUTICALS INC.
$76
Otsuka America Pharmaceutical, Inc.
$71
Teva Pharmaceuticals USA, Inc.
$67
Lilly USA, LLC
$62
SK Life Science, Inc.
$55
PFIZER INC.
$52
Neurocrine Biosciences, Inc.
$50
Kyowa Kirin, Inc.
$40
HARMONY BIOSCIENCES LLC
$37
Aucta Pharmaceuticals, Inc.
$25
Takeda Pharmaceuticals U.S.A., Inc.
$18
Top 3 companies account for 26.7% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$1,223
Biogen, Inc.
$850
Alexion Pharmaceuticals, Inc.
$577
ABBVIE INC.
$560
ACADIA Pharmaceuticals Inc
$519
Sunovion Pharmaceuticals Inc.
$502
Novartis Pharmaceuticals Corporation
$438
Sumitomo Pharma America, Inc.
$376
Teva Pharmaceuticals USA, Inc.
$324
Lilly USA, LLC
$308
Amgen Inc.
$299
JAZZ PHARMACEUTICALS INC.
$298
Lundbeck LLC
$268
Janssen Pharmaceuticals, Inc
$264
MDD US Operations, LLC
$252
CSL Behring
$234
ARGENX US, INC.
$219
Biohaven Pharmaceuticals, Inc.
$218
UPSHER-SMITH LABORATORIES LLC
$214
Greenwich Biosciences, Inc.
$212
Grifols USA, LLC
$211
GENZYME CORPORATION
$207
Otsuka America Pharmaceutical, Inc.
$205
US WorldMeds, LLC
$180
ANI Pharmaceuticals, Inc.
$168
PFIZER INC.
$166
Eisai Inc.
$162
Neurelis, Inc.
$159
Kyowa Kirin, Inc.
$153
AbbVie Inc.
$143
LivaNova USA, Inc.
$141
EMD Serono, Inc.
$137
Neurocrine Biosciences, Inc.
$128
AstraZeneca Pharmaceuticals LP
$127
Mallinckrodt Hospital Products Inc.
$123
Amneal Pharmaceuticals LLC
$119
Genentech USA, Inc.
$110
SK Life Science, Inc.
$109
HARMONY BIOSCIENCES LLC
$108
W. L. Gore & Associates, Inc.
$106
Biohaven Pharmaceutical Holding Company Ltd.
$95
ARBOR PHARMACEUTICALS, INC.
$68
Adamas Pharmaceuticals, Inc.
$54
Upsher-Smith Laboratories LLC
$50
Corium, LLC
$50
Avanir Pharmaceuticals, Inc.
$41
Harmony Biosciences LLC
$41
Impax Laboratories, Inc.
$38
Acorda Therapeutics, Inc
$38
GE HEALTHCARE
$34
Allergan Inc.
$33
Arbor Pharmaceuticals, Inc.
$31
Mallinckrodt Enterprises LLC
$26
Aucta Pharmaceuticals, Inc.
$25
EISAI INC.
$24
Supernus Pharmaceuticals, Inc.
$23
BANNER LIFE SCIENCES, LLC
$23
Mitsubishi Tanabe Pharma America, Inc.
$22
IMPEL PHARMACEUTICALS INC.
$22
SANOFI-AVENTIS U.S. LLC
$22
Genentech, Inc.
$20
Mylan Pharmaceuticals Inc.
$19
Takeda Pharmaceuticals U.S.A., Inc.
$18
Ipsen Biopharmaceuticals, Inc
$16
IDORSIA PHARMACEUTICALS US INC
$15
Allergan, Inc.
$14
Zyla Life Sciences
$14
Boston Scientific Corporation
$14
ASSERTIO THERAPEUTICS, Inc.
$14
OWP Pharmaceuticals, Inc.
$13
Top 3 companies account for 22.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BRILINTA · Briviact · CARDIOFORM Septal Occluder · COMIRNATY · COPAXONE · DUOPA · DYSPORT · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · Fycompa · GENERAL PAIN MANAGEMENT · GILENYA · GOCOVRI · GORE CARDIOFORM Septal Occluder · Gamunex-C · Glatiramer Acetate · Gocovri · Gralise · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · LUMIZYME · LYRICA · Leqembi · Motpoly XR · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · OCREVUS · ONFI · Ongentys · PAXLOVID · PLEGRIDY · PURIFIED CORTROPHIN GEL · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPRIX · Soliris · Subvenite · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VNS Therapy · VRAYLAR · VYEPTI · VYVGART · VYVGART HYTRULO · VascuClear · Vimpat · WAKIX · Wakix · XYWAV · Xadago · ZEMBRACE SYMTOUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
207
Per 100K population
26.9
County median income
$98,712
Nearest hospital
WELLSTAR COBB MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. McGaffigan is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. McGaffigan experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. McGaffigan performed 246 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. McGaffigan receive payments from pharmaceutical companies?
Yes. Dr. McGaffigan received a total of $12,034 from 70 companies across 612 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McGaffigan's costs compare to other neurologists in Austell?
Dr. McGaffigan's average Medicare payment per service is $104. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McGaffigan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Austell
Browse neurologists in Austell ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in GA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in GA
Which GA neurologists receive the most from drug and device companies.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology